ArticleFrontiers in oncology2017

Highly Specific and Effective Targeting of EGFRvIII-Positive Tumors with TandAb Antibodies.

Kristina Ellwanger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.